COVID shots cause a 25% increase in cardiac arrest and acute coronary syndrome in those under 40 years old

 

A study from MIT, Massachusetts General Hospital, Israel National Emergency Services, and Ben Gurion University showed a 25% increase in cardiac arrest and acute coronary syndrome calls since the COVID vaccines were started. [1]

The authors defined Cardiac Arrest (CA) as a sudden electrical malfunction of the heart of presumed cardiac or medical etiology, resulting in the collapse of a patient. Cardiac arrests related to trauma, drug overdose, or suicide are excluded. 

Acute Coronary Syndrome (ACS) calls were defined as conditions where the patients experience a reduction in blood flow to the heart associated with myocardial infarction.

ACS diagnosis was made based on the patient’s 12-lead ECG (a 12-lead ECG was performed on all patients suspected of ACS to confirm the diagnosis), symptoms (e.g., chest pain, shortness of breath), medical history, and physical examination, as obtained by the responding paramedics.  

The study included all calls to the EmergencyMedical Services (EMS) for all cardiac arrest and acute coronary syndrome in Israel over two and half years. 

The EMS data is more comprehensive regarding CA and ACS than adverse event self-reporting surveillance systems like the Vaccine Adverse Reporting System (VAERS).

Findings

The main finding of this study is the increase of over 25% in both the number of cardiac arrest calls and Acute Coronary Syndrome calls of people in the 16–39 age group during the COVID-19 vaccination rollout in Israel (January–May 2021), compared with the same period of time in prior years (2019 and 2020).

 

Moreover, there is a robust and statistically significant association between the weekly cardiac arrest and Acute Coronary Syndrome calls, and the rates of first and second vaccine doses administered to this age group.

 

The increase in CA and ACS calls starting early January 2021 seems to track closely the administration of 2nd dose vaccines

In the figures below, notice the rise in cardiac arrest and acute coronary syndrome calls (red) after receipt of the first vaccine doses (purple) and second vaccine doses (blue).

Cardiac Arrest

Source: Increased emergency cardiovascular events among the under-40 population in Israel during vaccine rollout and third COVID-19 wave

Acute Coronary Syndrome

Source: Increased emergency cardiovascular events among the under-40 population in Israel during vaccine rollout and third COVID-19 wave

At the same time, there is no statistically significant association between COVID-19 infection rates and cardiac arrest and acute coronary syndrome call counts.

A second increase in the cardiac arrest and acute coronary syndrome call counts is observed starting April 18th, 2021, which seems to track an increase of single-dose vaccination to individuals who recovered from COVID-19 infections.

The two figures below show the rise in cardiac arrest and acute coronary syndrome (red) calls around April 18, 2021, which follows suspected single vaccine doses for recovered individuals after April 1, 2021. (solid green)

Cardiac Arrest

Source: Increased emergency cardiovascular events among the under-40 population in Israel during vaccine rollout and third COVID-19 wave

Acute Coronary Syndrome

Source: Increased emergency cardiovascular events among the under-40 population in Israel during vaccine rollout and third COVID-19 wave

The increase in the CA and ACS events among the 16-39-year-old parallel to the vaccine rollout is consistent with the known causal relationship between the mRNA vaccines and the incidence of myocarditis in young people.

Myocarditis is often misdiagnosed as ACS, and that asymptomatic myocarditis is a frequent cause of sudden unexplained death among young adults.[2][3][4]

Females affected worse

While vaccine-induced myocarditis was predominantly reported in males it is interesting to note that the relative increases of CA and ACS events was larger in females.

The table below shows a higher percentage increase in cardiac arrest among females for 2021 (31.4) than males (25) among the 16-39 years old. Likewise, there is a higher increase in acute coronary syndromes in females (40.8) than males (21.3).

Source: Increased emergency cardiovascular events among the under-40 population in Israel during vaccine rollout and third COVID-19 wave

That is why acute coronary syndromes should be ruled out among young females with chest pains and shortness of breath who received COVID shots.

ACS may be unreported in this paper

Despite the concerning increase of 25% in  ACS among young people, the authors admit that it may be underreported since only patients brought in by the ambulances are counted. Patients who are “walk-ins” to the emergency rooms and their physicians are not counted. To the authors, the undercount could be 50%.

This paper has several policy implications, according to the author.
  1. COVID vaccine surveillance programs should include EMS records.
  2. There should be increased awareness among patients and clinicians about ACS following vaccination or COVID-19 infection to ensure that potential harm is minimized. This is especially important among the younger population, particularly young females, who often receive a less diagnostic evaluation for adverse cardiac events than males. Furthermore, there is still a push for booster shots since the antibodies induced by the vaccines wane after several months. 
  3. In the meantime, patients young and old should be instructed to seek medical care if they experience chest pain or shortness of breath and avoid strenuous physical activity following vaccination that may lead to serious cardiac events.

My opinion

This paper sheds light on my previous article, US data: High numbers of autopsies done in 2021 among 15-64 years old. Patients who die without a history of cardiovascular risk factors get autopsied.

Right now, it looks like getting a COVID shot can be considered a risk factor for acute coronary syndrome and cardiac arrest. 

Some may say that the risk is tolerable since the COVID shots protect against severe disease. In a TV interview, Prof. Jacob Giris, director of Ichilov Hospital’s coronavirus ward, said many severe cases are vaccinated. (Emphasis added)

“Right now, most of our severe cases are vaccinated,” Giris told Channel 13 News. “They had at least three injections. Between seventy and eighty percent of the serious cases are vaccinated.

 

So, the vaccine has no significance regarding severe illness, which is why just twenty to twenty-five percent of our patients are unvaccinated.”

The three COVID injections that those patients received did not protect them against severe COVID but increased their risk for cardiac disease.

 

Truth heals, Lies kill. Don’t Get Sick!

Knowledge about Covid-19 is rapidly evolving. Stay current by subscribing. Feel free to share and like.

If you find value in this website, please consider donating to show your support.

Related: 

  1. Tinnitus, hearing loss, and vertigo after COVID vaccines
  2. The Moderna patented genetic sequence in SARS-CoV-2 makes it more infectious
  3. The Complete List of the Pfizer Adverse Events of Special Interest
  4. Pfizer COVID shot makes human liver cells produce SARS-CoV-2 spike DNA
  5. Risk-benefit analysis shows a higher risk of COVID vax death than COVID-19 disease for those under 80 years old
  6. Stanford study shows spike proteins in the blood for two days and lymph nodes for sixty days post COVID vaccination
  7. Rapid Progression of a Lymphoma following Pfizer booster shot
  8. 13 ways that the SARS-CoV-2 spike protein causes damage
  9. SARS-CoV-2 spike proteins detected in the plasma following Moderna shots
  10. Higher blood pressure after COVID shots and why it happens

References:

  1. Sun, C.L.F., Jaffe, E. & Levi, R. Increased emergency cardiovascular events among the under-40 population in Israel during vaccine rollout and third COVID-19 waveSci Rep 12, 6978 (2022).  https://doi.org/10.1038/s41598-022-10928-z
  2. Feldman, A. M. & McNamara, D. MyocarditisN. Engl. J. Med. 343, 1388–1398 (2000).
  3. Ali-Ahmed, F., Dalgaard, F. & Al-Khatib, S. M. Sudden cardiac death in patients with myocarditis: Evaluation, risk stratification, and management. Am. Heart J. 220, 29– 40.  (2020).
  4. Drory, Y. et al. Sudden unexpected death in persons less than 40 years of ageAm. J. Cardiol. 68, 1388–1392.  (1991).

© 2018 – 2022 Asclepiades Medicine, L.L.C. All Rights Reserved
DrJesseSantiano.com does not provide medical advice, diagnosis, or treatment

As an Amazon Associate, I earn from qualifying purchases.